Evidence map›Paper›PMID 34828360›Full record

ArticleGenes2021

Molecular Classification and Interpretation of Amyotrophic Lateral Sclerosis Using Deep Convolution Neural Networks and Shapley Values.

Abdul Karim, Zheng Su, Phillip K West, Matthew Keon, The Nygc Als Consortium, Jannah Shamsani, Samuel Brennan, Ted Wong, Ognjen Milicevic, Guus Teunisse and 2 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. A neuromuscular clinician's primer on machine learning.Journal of neuromuscular diseases · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Abdul KarimGenieUs Genomics, 19a Boundary St, Darlinghurst, NSW 2010, Australia.
Zheng SuGenieUs Genomics, 19a Boundary St, Darlinghurst, NSW 2010, Australia.
Phillip K WestGenieUs Genomics, 19a Boundary St, Darlinghurst, NSW 2010, Australia.
Matthew KeonGenieUs Genomics, 19a Boundary St, Darlinghurst, NSW 2010, Australia.
The Nygc Als ConsortiumThe New York Genome Center, 101 Avenue of the Americas, New York, NY 10013, USA.
Jannah ShamsaniGenieUs Genomics, 19a Boundary St, Darlinghurst, NSW 2010, Australia.
Samuel BrennanGenieUs Genomics, 19a Boundary St, Darlinghurst, NSW 2010, Australia.
Ted WongGenieUs Genomics, 19a Boundary St, Darlinghurst, NSW 2010, Australia.
Ognjen MilicevicGenieUs Genomics, 19a Boundary St, Darlinghurst, NSW 2010, Australia.
Guus TeunisseGenieUs Genomics, 19a Boundary St, Darlinghurst, NSW 2010, Australia.
Hima Nikafshan RadInstitute of Integrated and Intelligent Systems, Griffith University, Nathan, QLD 4111, Australia.
Abdul SattarInstitute of Integrated and Intelligent Systems, Griffith University, Nathan, QLD 4111, Australia.
Griffith University · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a prototypical neurodegenerative disease characterized by progressive degeneration of motor neurons to severely effect the functionality to control voluntary muscle movement. Most of the non-additive genetic aberrations responsible for ALS make its molecular classification very challenging along with limited sample size, curse of dimensionality, class imbalance and noise in the data. Deep learning methods have been successful in many other related areas but have low minority class accuracy and suffer from the lack of explainability when used directly with RNA expression features for ALS molecular classification. In this paper, we propose a deep-learning-based molecular ALS classification and interpretation framework. Our framework is based on training a convolution neural network (CNN) on images obtained from converting RNA expression values into pixels based on DeepInsight similarity technique. Then, we employed Shapley additive explanations (SHAP) to extract pixels with higher relevance to ALS classifications. These pixels were mapped back to the genes which made them up. This enabled us to classify ALS samples with high accuracy for a minority class along with identifying genes that might be playing an important role in ALS molecular classifications. Taken together with RNA expression images classified with CNN, our preliminary analysis of the genes identified by SHAP interpretation demonstrate the value of utilizing Machine Learning to perform molecular classification of ALS and uncover disease-associated genes.

Indexed as

AlgorithmsAmyotrophic Lateral SclerosisDatabases, GeneticDeep LearningGene Expression ProfilingGene Expression RegulationHumansImage Interpretation, Computer-AssistedNeural Networks, ComputerRNA, MessengerSequence Analysis, RNARNA, MessengerALSclassificationinterpretationmachine learningtarget identification

Identifiers

PMID34828360
PMCPMC8626003
OpenAlexW3209178467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.